Amendment106th Congress
975
- Amendment Number
- 975
- Purpose
- An amendment numbered 37 printed in the Congressional Record to add a provision to the bill that prohibits the use of funds from being used to approve any application for a new drug submitted by an entity that does not agree to a quarterly disclosure of the average price charged by the manufacturer for the most common dosage of the drug in each country that is a member of OECD.
- Congress
- 106
- Type
- HAMDT
- Latest Action Date
- Jul 11, 2000
- Latest Action Text
- By unanimous consent, the Brown (OH) amendment was withdrawn.
- Latest Action Time
- 13:39:59
- Submitted Date
- Jul 11, 2000
- Chamber
- House of Representatives
- Update Date
- Aug 15, 2021